FIG 6.

NEK9 and GMIP contribute to p21 induction by BGLF2. (A) CNE2Z cells were treated with siRNA against NEK9 or GMIP or negative-control siRNA (AllStars). Cell lysates were then analyzed by Western blotting for p53, p21, NEK9, GMIP, and actin. (B) CNE2Z cells were treated with siRNA targeted to NEK9 or GMIP or with AllStars negative-control siRNA and then were transfected with pMZS3F or pMZS3F-BGLF2. Twenty-four hours later, cell lysates were analyzed by Western blotting using the indicated antibodies.